These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 29099746)

  • 1. Biology of the BKPyV: An Update.
    Helle F; Brochot E; Handala L; Martin E; Castelain S; Francois C; Duverlie G
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29099746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MICA Mutant A5.1 Influences BK Polyomavirus Reactivation and Associated Nephropathy After Kidney Transplantation.
    Tonnerre P; Gérard N; Gavlovsky PJ; Mazalrey S; Hourmant M; Cheneau ML; Cesbron-Gautier A; Renaudin K; Bressollette-Bodin C; Charreau B
    J Infect Dis; 2016 Sep; 214(5):807-16. PubMed ID: 27130430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human polyomavirus BK (BKPyV): virological background and clinical implications.
    Rinaldo CH; Tylden GD; Sharma BN
    APMIS; 2013 Aug; 121(8):728-45. PubMed ID: 23782063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
    Pape L; Tönshoff B; Hirsch HH;
    Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for BK Polyoma Virus Treatment and Association of Treatment With Kidney Transplant Failure: Insights From a Paired Kidney Analysis.
    Thangaraju S; Gill J; Wright A; Dong J; Rose C; Gill J
    Transplantation; 2016 Apr; 100(4):854-61. PubMed ID: 27003098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions.
    Sharma R; Tzetzo S; Patel S; Zachariah M; Sharma S; Melendy T
    Exp Clin Transplant; 2016 Aug; 14(4):377-84. PubMed ID: 27267780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation.
    Ahlenstiel-Grunow T; Sester M; Sester U; Hirsch HH; Pape L
    Transplantation; 2020 Nov; 104(11):2393-2402. PubMed ID: 31985731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BK and JC polyomavirus infections in Tunisian renal transplant recipients.
    Boukoum H; Nahdi I; Sahtout W; Skiri H; Aloui S; Achour A; Segondy M; Aouni M
    J Med Virol; 2015 Oct; 87(10):1788-95. PubMed ID: 25952258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
    Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
    BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.
    Abudayyeh A; Hamdi A; Abdelrahim M; Lin H; Page VD; Rondon G; Andersson BS; Afrough A; Martinez CS; Tarrand JJ; Kontoyiannis DP; Marin D; Gaber AO; Oran B; Chemaly RF; Ahmed S; Abudayyeh I; Olson A; Jones R; Popat U; Champlin RE; Shpall EJ; Rezvani K
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27862740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cell Culture Model of BK Polyomavirus Persistence, Genome Recombination, and Reactivation.
    Zhao L; Imperiale MJ
    mBio; 2021 Oct; 12(5):e0235621. PubMed ID: 34473564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
    Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
    Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically Relevant Reactivation of Polyomavirus BK (BKPyV) in HLA-A02-Positive Renal Transplant Recipients Is Associated with Impaired Effector-Memory Differentiation of BKPyV-Specific CD8+ T Cells.
    van Aalderen MC; Remmerswaal EB; Heutinck KM; Ten Brinke A; Feltkamp MC; van der Weerd NC; van der Pant KA; Bemelman FJ; van Lier RA; Ten Berge IJ
    PLoS Pathog; 2016 Oct; 12(10):e1005903. PubMed ID: 27723787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of immune suppressive agents on the BK-Polyomavirus non coding control region.
    Korth J; Anastasiou OE; Verheyen J; Dickow J; Sertznig H; Frericks N; Bleekmann B; Kribben A; Brinkhoff A; Wilde B; Sutter K; Dittmer U; Ciesek S; Witzke O; Widera M
    Antiviral Res; 2018 Nov; 159():68-76. PubMed ID: 30268912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
    Al-Raisi F; Mohsin N; Kamble P
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.
    Ambalathingal GR; Francis RS; Smyth MJ; Smith C; Khanna R
    Clin Microbiol Rev; 2017 Apr; 30(2):503-528. PubMed ID: 28298471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation.
    Korth J; Anastasiou OE; Bräsen JH; Brinkhoff A; Lehmann U; Kribben A; Dittmer U; Verheyen J; Wilde B; Ciesek S; Witzke O; Widera M
    J Clin Virol; 2019 Apr; 113():14-19. PubMed ID: 30771597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
    Shah T; Vu D; Naraghi R; Campbell A; Min D
    Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BK and JC virus infections in healthy patients compared to kidney transplant recipients in Tunisia.
    Boukoum H; Nahdi I; Sahtout W; Skiri H; Segondy M; Aouni M
    Microb Pathog; 2016 Aug; 97():204-8. PubMed ID: 27317859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.